Sort
85,873 grants matching “alzheimers”
Integrative Biology Approach to Complexity of Alzheimer's Disease
$1,659,748Eric E Schadt · Icahn School Of Medicine At Mount Sinai · U01 · FY2013 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
$1,659,230Rima F Kaddurah-Daouk · Duke University · U01 · FY2018 · AG
Biological And Biochemical Characterization Of Sigma Receptors
$1,659,040Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2015 · DA
Genomic regulation of immune response in neurodegeneration in mice
$1,658,990Han-Yu Shih · National Eye Institute · ZIA · FY2023 · EY
CENTER FOR CAM RESEARCH IN AGING
$1,658,755Columbia University Health Sciences · P50 · FY2002 · AT
The Biophysics Collaborative Access Team
$1,658,735Thomas C Irving · Illinois Institute Of Technology · P41 · FY2016 · GM
Role of APOE in endosomal processing of alpha-synuclein
$1,658,363Albert A Davis · Washington University · RF1 · FY2023 · AG
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
$1,658,363Susan Cheng · Cedars-Sinai Medical Center · U54 · FY2023 · AG
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions
$1,658,307Sally Temple · Regenerative Research Foundation · U01 · FY2021 · AG
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease
$1,657,941Stephen M Strittmatter · Yale University · U01 · FY2019 · AG
Neurobiology of Alzheimer's Disease and Aging
$1,657,884Roger Rosenberg · Ut Southwestern Medical Center · P30 · FY2015 · AG
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-alpha1 in Neural and Cognitive Functions
$1,657,591Y. Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging
$1,657,167William J. Jagust · University Of California Berkeley · U24 · FY2020 · AG
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
$1,657,121Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · AG
Silent Allosteric Modulation of mGluR5 for Safe and Effective Therapy of Alzheimer's Disease
$1,657,037Stephen M Strittmatter · Yale University · U01 · FY2022 · AG
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,656,954Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Higher Order Chromatin and Genetic Risk for Alzheimer's Disease
$1,656,556Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AG
Neurobiology of Alzheimer's Disease and Aging
$1,656,440Roger Rosenberg · Ut Southwestern Medical Center · P30 · FY2008 · AG
Pre-Clinical Testing Core
$1,656,121Paul Richard Territo · Indiana University Indianapolis · U54 · FY2021 · AG
University of Kentucky Alzheimer's Disease Core Center
$1,655,500Linda J Van Eldik · University Of Kentucky · P30 · FY2018 · AG
University of Kentucky Alzheimer's Disease Core Center
$1,655,500Linda J Van Eldik · University Of Kentucky · P30 · FY2016 · AG
University of Kentucky Alzheimer's Disease Core Center
$1,655,500Linda J Van Eldik · University Of Kentucky · P30 · FY2017 · AG
Main Administrative Core
$1,655,488Anne M Murray · Hennepin Healthcare Research Institute · U19 · FY2019 · AG
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies
$1,655,392Thomas J Montine · Stanford University · U01 · FY2024 · AG
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
$1,654,767Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · AG